Concourse Financial Group Securities, Inc. Cv Rx, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.52 Billion
- Q1 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Cv Rx, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 560 shares of CVRX stock, worth $6,714. This represents 0.0% of its overall portfolio holdings.
Number of Shares
560
Previous 560
-0.0%
Holding current value
$6,714
Previous $17,000
41.18%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CVRX
# of Institutions
91Shares Held
13.8MCall Options Held
264KPut Options Held
89.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$49.2 Million15.74% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$28.4 Million3.03% of portfolio
-
Black Rock Inc. New York, NY765KShares$9.17 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL619KShares$7.42 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$7.13 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $247M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...